We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$19.1B
AUM Growth
-$71.6M
Cap. Flow
+$375M
Cap. Flow %
1.97%
Top 10 Hldgs %
20.96%
Holding
1,713
New
9
Increased
554
Reduced
98
Closed
38

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$83.2M
2
DQ
Daqo New Energy
DQ
+$42.7M
3
DAR icon
Darling Ingredients
DAR
+$33M
4
TER icon
Teradyne
TER
+$25.8M
5
IQV icon
IQVIA
IQV
+$25.1M

Sector Composition

Rank Sector Weight
1 Technology 24.47%
2 Healthcare 17.68%
3 Consumer Discretionary 14.03%
4 Financials 13.08%
5 Industrials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMWD
1626
DELISTED
American Woodmark
AMWD
$240K ﹤0.01%
3,672
OMER icon
1627
Omeros
OMER
$1.22B
$239K ﹤0.01%
17,300
TVRD
1628
Tvardi Therapeutics
TVRD
$22M
$239K ﹤0.01%
431
GBIO
1629
DELISTED
Generation Bio
GBIO
$238K ﹤0.01%
950
AMTI
1630
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$238K ﹤0.01%
9,200
JBLU icon
1631
JetBlue
JBLU
$2.21B
$237K ﹤0.01%
15,500
SKYW icon
1632
Skywest
SKYW
$4.17B
$237K ﹤0.01%
4,800
SFL icon
1633
SFL Corp
SFL
$1.62B
$236K ﹤0.01%
28,200
+10,200
+57% +$77.2K
ACCO icon
1634
Acco Brands
ACCO
$404M
$233K ﹤0.01%
27,176
NTGR icon
1635
NETGEAR
NTGR
$653M
$231K ﹤0.01%
7,230
PBI icon
1636
Pitney Bowes
PBI
$2.31B
$231K ﹤0.01%
32,100
HFWA icon
1637
Heritage Financial
HFWA
$1.23B
$230K ﹤0.01%
9,023
AMCX icon
1638
AMC Global Media
AMCX
$500M
$228K ﹤0.01%
4,902
CELL
1639
DELISTED
PhenomeX Inc. Common Stock
CELL
$227K ﹤0.01%
11,600
AMRX icon
1640
Amneal Pharmaceuticals
AMRX
$6.15B
$226K ﹤0.01%
42,274
FARO
1641
DELISTED
Faro Technologies
FARO
$224K ﹤0.01%
3,400
+800
+31% +$56.3K
GRPN icon
1642
Groupon
GRPN
$882M
$224K ﹤0.01%
9,817
WW
1643
DELISTED
WW International
WW
$220K ﹤0.01%
12,058
EBIX
1644
DELISTED
Ebix Inc
EBIX
$220K ﹤0.01%
8,165
RUBY
1645
DELISTED
Rubius Therapeutics, Inc
RUBY
$218K ﹤0.01%
12,200
MDGL icon
1646
Madrigal Pharmaceuticals
MDGL
$12.3B
$215K ﹤0.01%
2,700
KRON
1647
DELISTED
Kronos Bio
KRON
$212K ﹤0.01%
10,100
OFIX icon
1648
Orthofix Medical
OFIX
$419M
$212K ﹤0.01%
5,558
EHTH icon
1649
eHealth
EHTH
$39.7M
$211K ﹤0.01%
5,200
RMAX icon
1650
RE/MAX Holdings
RMAX
$265M
$211K ﹤0.01%
6,765

Similar funds

Handelsbanken Fonder's Q3 2021 Portfolio in Review

As of Q3 2021, Handelsbanken Fonder held 1,713 positions worth $19.1B, down 0.37% from $19.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.7%. Handelsbanken Fonder opened 9 new positions and exited 38, leaving the 1,713-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q3 2021 buy was Volta Inc.: 1,671,677 shares worth $14.5M.
  • Handelsbanken Fonder added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $83.2M increase.
  • Handelsbanken Fonder's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.3M.
  • Handelsbanken Fonder fully exited Johnson Controls International in Q3 2021, selling an estimated $19.2M.
  • Handelsbanken Fonder's ten largest holdings make up 21% of its $19.1B portfolio in Q3 2021.
  • Handelsbanken Fonder opened 9 new positions and closed 38 in Q3 2021.
  • Handelsbanken Fonder's portfolio value fell 0.37% quarter-over-quarter to $19.1B.

Based on Handelsbanken Fonder's 13F filing for Q3 2021, filed 10 Nov 2021.